setA Antibody

What is SETA and what are the primary types of SETA antibodies available for research?

SETA (also known as CIN85/Ruk/SH3KBP1) is an adaptor protein involved in regulating diverse signal transduction pathways, including the internalization of tyrosine kinase receptors via Cbl ubiquitin ligases and attenuating PI3K activity. Two main types of SETA antibodies are available for research: polyclonal anti-Set1A antibodies and monoclonal anti-SETA/CIN85/Ruk/SH3KBPI antibodies (such as clone 84). The polyclonal antibodies are suitable for ChIP and Western blot applications with reactivity against human, rat, and mouse samples, while monoclonal antibodies are validated for immunocytochemistry, immunoprecipitation, and Western blot applications .

What cellular functions is SETA protein involved in, and why is it relevant to study?

SETA protein functions as a critical adaptor in multiple cellular pathways. Research has shown that SETA co-localizes with actin in microfilaments and at focal adhesions, as well as with microtubules, indicating its involvement in cytoskeletal organization. SETA interacts with focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK-2), promoting cell adhesion, while its binding partner AIP1 reduces cell adhesion. These interactions make SETA relevant to studying signal transduction, cell adhesion, cytoskeletal dynamics, and potentially cancer cell migration and invasion .

How should SETA antibodies be stored and handled for optimal stability?

For optimal stability and performance, SETA antibodies should be stored according to manufacturer specifications, typically at -20°C for long-term storage, with working aliquots maintained at 4°C for up to one month. Repeated freeze-thaw cycles should be avoided as they can lead to denaturation and loss of antibody activity. When handling these antibodies for experimental procedures, it's advisable to keep them on ice, avoid vigorous shaking, and use sterile pipette tips. Dilution in appropriate buffers containing stabilizing proteins (such as BSA) can help maintain antibody functionality during experimentation .

How can SETA-670 fluorophore labeling enhance single molecule studies of antibodies?

The methodological approach involves labeling antibodies (such as anti-rabbit IgG) with Seta-670-mono-NHS containing a reactive succinimidyl ester moiety using Na-bicarbonate buffer (0.1 M, pH 8.3), followed by size-exclusion chromatography purification. Single molecule measurements can be performed using systems like MicroTime 200 with pulsed laser diodes (635 nm, 20 MHz repetition rate) and detectors with time responses around 300 ps .

What are the optimal conditions for detecting protein-protein interactions involving SETA using immunoprecipitation techniques?

For detecting protein-protein interactions involving SETA using immunoprecipitation (IP), researchers should optimize several critical parameters. Anti-SETA/CIN85/Ruk/SH3KBPI antibodies (clone 84) have been validated for immunoprecipitation applications with human, rat, and mouse samples.

The optimal protocol typically involves:

• Cell lysis in a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, with protease and phosphatase inhibitors

• Pre-clearing lysates with protein A/G beads

• Overnight incubation with anti-SETA antibodies at 4°C

• Capturing immune complexes with protein A/G beads

• Washing under stringent conditions to remove non-specific interactions

• Elution and analysis by SDS-PAGE and Western blotting

When investigating SETA interactions with focal adhesion kinases (FAK, PYK-2), it's important to note that SETA forms dimers when interacting with these proteins, and phosphorylation state significantly influences binding affinity. Detection of these complexes often requires optimization of detergent concentrations to preserve native protein conformations while effectively solubilizing membrane-associated complexes .

How can researchers effectively distinguish between different isoforms of SETA/CIN85/Ruk in experimental systems?

Distinguishing between different isoforms of SETA/CIN85/Ruk requires careful selection of antibodies and analytical techniques. Since SETA has multiple isoforms resulting from alternative splicing and different promoter usage, researchers should:

• Select antibodies with epitopes specific to the isoform of interest

• Use high-resolution SDS-PAGE (10-12% gels) with extended running times to separate closely migrating isoforms

• Employ 2D gel electrophoresis when post-translational modifications affect isoform identification

• Consider using isoform-specific PCR primers for transcript analysis in parallel with protein detection

• Validate antibody specificity using knockout/knockdown models or overexpression systems

For Western blot applications, reducing sample heating time and temperature can help preserve epitope recognition for certain isoforms. When working with tissue samples, it's important to note that isoform expression varies significantly between tissues, with some isoforms showing tissue-specific expression patterns. Quantitative analysis should include appropriate normalization controls specific to each tissue type .

What are common causes of high background when using SETA antibodies in immunocytochemistry, and how can they be resolved?

High background in immunocytochemistry (ICC) with SETA antibodies can result from several factors. The most common causes and their solutions include:

• Insufficient blocking:

  • Increase blocking time (2-3 hours at room temperature or overnight at 4°C)

  • Try different blocking agents (5% BSA, 5-10% normal serum, or commercial blocking buffers)

  • Add 0.1-0.3% Triton X-100 to blocking buffer for better penetration

• Excessive antibody concentration:

  • Titrate primary antibody (typical working dilutions range from 1:100 to 1:1000)

  • Extend primary antibody incubation time while decreasing concentration

  • Perform sequential dilution tests to determine optimal concentration

• Cross-reactivity issues:

  • Pre-adsorb antibody with cell/tissue lysates from species not being studied

  • Switch to more specific monoclonal antibodies like anti-SETA/CIN85/Ruk clone 84

  • Use isotype controls to determine non-specific binding

• Fixation artifacts:

  • Compare different fixation methods (4% paraformaldehyde often works well for SETA detection)

  • Reduce fixation time

  • Include antigen retrieval steps if needed

Additionally, when detecting SETA's interaction with cytoskeletal elements, preserving both cytoskeletal architecture and SETA localization can be challenging. Using cytoskeleton stabilizing buffers during fixation can help maintain these structures for accurate co-localization analysis .

How should researchers design experiments to investigate SETA's role in cell adhesion dynamics?

Designing experiments to investigate SETA's role in cell adhesion dynamics requires a multifaceted approach:

• Cell adhesion quantification:

  • Implement electrical cell-substrate impedance sensing (ECIS) to measure real-time adhesion changes

  • Compare adhesion behavior in cells overexpressing SETA versus those overexpressing AIP1 or c-Cbl

  • Use time-lapse imaging with fluorescently tagged adhesion proteins to track dynamic changes

• Molecular interaction analysis:

  • Perform co-immunoprecipitation studies to detect SETA interactions with FAK and PYK-2

  • Investigate the requirement for SETA dimerization in promoting these interactions

  • Assess phosphorylation states of focal adhesion proteins using phospho-specific antibodies

• Functional manipulation:

  • Design SETA mutants lacking specific domains to identify regions required for adhesion effects

  • Use siRNA knockdown or CRISPR-Cas9 knockout approaches to eliminate SETA expression

  • Rescue experiments with wild-type versus mutant SETA to confirm specificity

• Visualization strategies:

  • Employ super-resolution microscopy to visualize SETA localization at focal adhesions

  • Use FRET-based approaches to measure direct protein interactions in living cells

  • Perform co-localization studies with established focal adhesion markers

These experimental designs should include appropriate controls, such as comparing AIP1 mutants with altered Y319 phosphorylation sites, which have been shown to correlate with their ability to decrease cell adhesion in ECIS analysis .

What approaches can resolve discrepancies in antibody-based detection of SETA across different experimental systems?

Resolving discrepancies in SETA detection across different experimental systems requires systematic troubleshooting and standardization approaches:

• Antibody validation protocol:

  • Test antibody specificity across multiple systems using SETA-knockout controls

  • Perform epitope mapping to identify potential sequence variations affecting binding

  • Compare multiple commercial antibodies targeting different SETA epitopes

  • Validate each lot of antibody with positive control samples

• Sample preparation standardization:

  • Optimize protein extraction protocols for different sample types

  • Compare different lysis buffers to ensure complete solubilization

  • Standardize protein quantification methods to ensure equal loading

  • Test multiple fixation protocols for immunohistochemistry/immunocytochemistry

• Detection method optimization:

  • For Western blotting: Compare different membrane types (PVDF vs. nitrocellulose)

  • For immunofluorescence: Test various amplification systems

  • For flow cytometry: Optimize permeabilization conditions

  • For all methods: Establish standard curves to determine linear detection ranges

• Data analysis standardization:

  • Use digital image analysis software with consistent thresholding parameters

  • Implement appropriate normalization strategies

  • Apply statistical methods suitable for detecting significant differences

  • Consider batch effects when comparing data across experiments

When discrepancies persist, researchers should consider biological variables such as post-translational modifications, protein-protein interactions, or conformational changes that might mask epitopes in certain experimental conditions. Cross-validation with non-antibody methods (such as mass spectrometry or RNA analysis) can help resolve persistent discrepancies .

How are multiple-fluorophore labeled SETA antibodies advancing single-molecule imaging techniques?

Multiple-fluorophore labeled antibodies using dyes like SETA-670 are revolutionizing single-molecule imaging through several mechanisms:

The practical implementation involves specialized equipment like MicroTime 200 systems with pulsed laser diodes (635 nm, 20 MHz) and picosecond time resolution detectors. This approach allows researchers to observe antibody-antigen binding events at unprecedented temporal and spatial resolution, with applications ranging from fundamental biophysics to diagnostic development .

What does current research reveal about the relationship between SETA expression patterns and disease pathogenesis?

Current research on SETA expression patterns and disease pathogenesis reveals several important associations:

• Cancer biology:

  • SETA/CIN85/Ruk overexpression has been linked to increased invasiveness in several cancer types

  • Its interaction with c-Cbl regulates receptor tyrosine kinase degradation, affecting growth factor signaling

  • SETA's role in cell adhesion modulation may contribute to metastatic potential

• Neurological disorders:

  • SETA interactions with synaptic proteins influence neuronal plasticity

  • Altered expression has been observed in neurodegenerative conditions

  • Its cytoskeletal regulatory functions may impact neuronal morphology and function

• Mechanistic insights:

  • SETA promotes the formation of protein complexes at focal adhesions through interaction with FAK and PYK-2

  • Its binding partner AIP1 reduces focal adhesion kinase phosphorylation

  • SETA-mediated molecular interactions directly correlate with cellular adhesion behavior

• Tissue-specific manifestations:

  • Expression patterns vary significantly across tissues

  • Alternative splicing produces tissue-specific isoforms with distinct functions

  • Post-translational modifications like phosphorylation regulate SETA activity in a context-dependent manner

These findings suggest SETA could be a potential therapeutic target, particularly in cancers where dysregulated cell adhesion and receptor trafficking contribute to disease progression. Detecting altered SETA expression or localization could potentially serve as a biomarker for certain pathological states .

How can researchers optimize multiple-parameter analysis when studying SETA and its binding partners in complex cellular systems?

Optimizing multiple-parameter analysis for SETA and its binding partners in complex cellular systems requires integrated methodological approaches:

• Multiplexed detection strategies:

  • Use spectrally distinct fluorophores to simultaneously detect SETA, AIP1, FAK, and PYK-2

  • Implement sequential antibody labeling with careful antibody stripping validation

  • Utilize proximity ligation assays to visualize specific protein-protein interactions in situ

  • Apply mass cytometry (CyTOF) for simultaneous detection of >40 parameters in heterogeneous samples

• Live-cell dynamics analysis:

  • Design fluorescent protein fusion constructs for SETA and binding partners

  • Implement FRET/FLIM approaches to measure dynamic interactions

  • Use photoactivatable or photoconvertible tags for pulse-chase analysis

  • Apply lattice light-sheet microscopy for long-term 3D imaging with reduced phototoxicity

• Correlative microscopy approaches:

  • Combine live-cell imaging with subsequent immunofluorescence

  • Implement correlative light and electron microscopy (CLEM) to link functional data with ultrastructural context

  • Use bioorthogonal click chemistry to label specific populations of newly synthesized proteins

• Integrated data analysis pipelines:

  • Develop machine learning algorithms for automatic detection of protein complexes

  • Implement trajectory analysis for tracking molecular dynamics

  • Utilize network analysis tools to map interaction landscapes

  • Apply computational modeling to predict functional outcomes of observed molecular events

These approaches should incorporate appropriate controls, including single-parameter measurements to establish baseline behavior, validation with multiple methodologies, and careful consideration of potential artifacts. Quantitative analysis should include both population-level statistics and single-cell analysis to capture heterogeneity within complex systems .

What emerging technologies might enhance the specificity and sensitivity of SETA antibody-based detection methods?

Several emerging technologies hold promise for enhancing the specificity and sensitivity of SETA antibody-based detection:

• Next-generation antibody engineering:

  • Single-domain antibodies (nanobodies) with superior tissue penetration and reduced size

  • Recombinant antibody fragments with site-specific conjugation of reporter molecules

  • Affimer scaffolds as non-antibody binding proteins with high specificity

  • DNA-barcoded antibodies for ultrasensitive digital detection

• Advanced labeling strategies:

  • Quantum dots with enhanced brightness and photostability

  • Upconversion nanoparticles for background-free detection

  • Self-labeling protein tags (SNAP, CLIP, Halo) for site-specific fluorophore attachment

  • Click chemistry approaches for bioorthogonal labeling in complex environments

• Signal amplification methodologies:

  • DNA-based signal amplification techniques (HCR, RCA, CARD)

  • Photonic crystal enhancement of fluorescence signals

  • Lanthanide-based time-resolved fluorescence for elimination of autofluorescence

  • Single-molecule counting approaches using digital detection platforms

• Advanced detection instrumentation:

  • Super-resolution microscopy beyond the diffraction limit

  • Light sheet fluorescence microscopy for reduced phototoxicity

  • Mass spectrometry imaging for label-free detection

  • Integrated microfluidic devices for automated sample processing and analysis

These technologies, when applied to SETA antibody detection, could significantly lower detection limits, improve quantitative accuracy, enable multiplexed detection of multiple targets simultaneously, and provide spatial information about protein interactions at unprecedented resolution .

What computational approaches might improve analysis of SETA interaction networks in signal transduction pathways?

Advanced computational approaches for analyzing SETA interaction networks include:

• Network modeling and simulation:

  • Dynamic Bayesian networks to model temporal changes in SETA-mediated signaling

  • Ordinary differential equation-based models to simulate pathway dynamics

  • Agent-based models to capture emergent properties of SETA interaction networks

  • Constraint-based models to predict network behaviors under perturbations

• Machine learning applications:

  • Deep learning for pattern recognition in large-scale interaction datasets

  • Reinforcement learning to predict optimal experimental designs

  • Unsupervised clustering to identify functional modules within SETA networks

  • Transfer learning to integrate knowledge across multiple experimental systems

• Multi-omics data integration:

  • Correlation network analysis across transcriptomic, proteomic, and interactomic data

  • Causal inference methods to identify regulatory relationships

  • Dimension reduction techniques to identify key drivers in complex datasets

  • Graph theory approaches to characterize network topology and identify critical nodes

• Visual analytics tools:

  • Interactive visualization platforms for exploring high-dimensional data

  • Augmented reality interfaces for intuitive exploration of molecular interactions

  • Real-time analysis dashboards for monitoring experimental outputs

  • Collaborative annotation systems for community knowledge integration

These computational approaches can help researchers predict how perturbations to SETA and its partners might affect cellular behavior, design targeted interventions to modify specific pathway outputs, and generate testable hypotheses about previously uncharacterized interactions. Integration of experimental data with computational models creates an iterative cycle where predictions drive experiments and experimental results refine models .

How might understanding SETA antibody cross-reactivity advance epitope mapping and antibody engineering?

Understanding SETA antibody cross-reactivity has significant implications for epitope mapping and antibody engineering:

• Structural determinants of specificity:

  • Detailed analysis of cross-reactivity patterns can reveal conserved structural motifs

  • Crystallographic studies of antibody-antigen complexes identify key interaction residues

  • Molecular dynamics simulations predict conformational epitopes

  • Alanine scanning mutagenesis maps critical binding residues

• Advanced epitope mapping technologies:

  • High-throughput peptide arrays for linear epitope identification

  • Hydrogen-deuterium exchange mass spectrometry for conformational epitope mapping

  • Cryo-electron microscopy for structural analysis of antibody-antigen complexes

  • Phage display libraries for epitope profiling

• Rational antibody engineering applications:

  • Structure-guided mutations to enhance specificity for particular SETA isoforms

  • Framework modifications to reduce non-specific binding

  • Complementarity determining region (CDR) optimization for improved affinity

  • Introduction of site-specific conjugation sites for controlled labeling

• Therapeutic and diagnostic translation:

  • Development of highly specific antibodies for discriminating between related proteins

  • Creation of bispecific antibodies targeting SETA and its binding partners

  • Engineering antibodies with environmentally-responsive binding properties

  • Development of synthetic antibody mimetics with enhanced stability